想了解台灣新創公司的創業歷程嗎？對於國家生技園區能提供創業者何種幫助感到好奇嗎？那麼，你絕不能錯過六月份的BTBA線上講座！我們非常榮幸邀請到兩位在國家生技園區的新創公司負責人來分享他們的經驗。講者將分享如何將自己在國外大型藥廠的工作經驗帶回台灣，並創立公司；同時，他們還會分享台灣學術技術如何轉移到公司，並成功進軍美國市場的經驗。立即點擊下方連結，報名參加這場活動吧！
Would you like to learn about the entrepreneurial journey in Taiwanese startups? Are you curious about the support that the National Biotechnology Parks can offer to entrepreneurs? Then you definitely shouldn’t miss the online seminar in June hosted by BTBA! We are honored to invite two founders/directors from startups based in the National Biotechnology Research Parks to share their experiences. Our speakers will discuss how they brought their experience from working in major pharmaceutical companies abroad back to Taiwan to establish their own companies. They will also share their success stories of transferring academic technologies in Taiwan to their companies and entering the U.S. market. Don’t hesitate—click the link below to register for this event!
🗣️ 本實體活動全程以中文進行
▶️ 主題 / Topic: Startups at National Biotechnology Research Park
🕘 Time: 2024-05-19 (Sun)
▶️ 報名連結/RSVP: https://forms.gle/LbJc5d68JWP9ifxp9
▶️ Contact: BTBA聯絡窗口; btba@btbatw.org
▶️ Speakers:
| 👩💼 Dr. Tess Lu 呂采修 | Director (Research), Ochre Bio, Taiwan |
Director (Research), Ochre Bio, Taiwan
Trained as a scientist in epigenetics and metabolic diseases, Tess made her transition to the industry as a STAR Post-doctoral fellow at Novo Nordisk working on GLP-1’s regulation on appetite. She continued her career at Novo Nordisk as a scientist and senior scientist at the Stem Cell Department, setting up the first single-cell platform in the company. After her maternity break, she made the transition back to Taiwan and started the Taipei chapter as Research Director for Ochre Bio, a liver RNA-therapeutics company headquartered in Oxford UK.
Linkedin page: https://www.linkedin.com/in/tess-tsai-hsiu-lu-04286988/
Chairman, CEO, and Founder at Syncell, Taiwan
Dr. Jung-Chi Liao was a Research Fellow at Academia Sinica, Taiwan and an Assistant Professor at Columbia University, New York before he founded Syncell in 2020, a spinoff company with its innovative optoproteomics technology invented in his lab at Academia Sinica. Under his guidance, the Syncell team is advancing the Microscoop product development and business strategy to realize Syncell’s vision to become a dominant player in spatial omics. Dr. Liao takes a precision synergy approach to create a cooperative and efficient culture suitable for multidisciplinary communication. Having been immersed in the high-tech spinoff environment at MIT, Cal Berkeley, Stanford, and Columbia, he shapes Syncell to match the high caliber and advance toward a leading global life science technology company.
Linkedin page: https://www.linkedin.com/in/jung-chi-liao-b40b8b5/
Postdoctoral Associate at UMass Chan Medical School
Dr. Yang is a passionate scientist with expertise in rodent models, epigenetics, obesity/diabetes, and metabolism. He’s especially fascinated by the paternal intergenerational effect when encountering environmental factors. He worked at the Max Planck Institute of Immunobiology and Epigenetics and received his Ph.D. from the University of Freiburg, Germany. In his Ph.D. work, he focused on the role of Neuronatin (Nnat) in buffering metabolic variation as an outcome of overgrowth/obesity encountering unknown environmental factors. He observed a bi-stable body composition phenotype in the Nnat deficient mouse model and further explored the causal mechanism mediated by HDAC-related gene profile via genomic approaches. The key concept from the story is to reshape people’s views on obesity subtypes in mammals from mice to human beings. As a postdoctoral fellow, he joined Rando’s laboratory at UMass Chan Medical School, studying paternal epigenetic inheritance effect on offspring when parents are exposed to the high-fat diet or paternal aging.
Linkedin page: https://www.linkedin.com/in/leslie-chih-hsiang-yang-8176a79a/